Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk
Glenn N. Levine(American College of Cardiology), Neil A. Zakai, Anthony V. D’Amico(Brigham and Women's Hospital), Peter E. Clark(Levine Cancer Institute), Richard V. Milani, Robert H. Eckel(University of Colorado Anschutz Medical Campus), Peter Berger(University of Rostock), Matthew R. Smith(Massachusetts General Hospital), Arthur I. Sagalowsky(The University of Texas Southwestern Medical Center), Nancy L. Keating(Brigham and Women's Hospital)
Cited by 377
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k